Reimbursed with a limitationOriginator productATC A10BD07

Janumet

Janumet is an originator product from MSD Merck Sharp & Dohme AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 41.30 to CHF 103.55 depending on the pack; the patient co-payment is 40 per cent plus the deductible.

Core data

Authorisation holder
MSD Merck Sharp & Dohme AG
ATC code
A10BD07
IT group
07.06.20 Orale blutzuckersenkende Mittel
Active substances
Sitagliptinum, Metformini hydrochloridum
Preparation type
Originator product
On the SL since
01/05/2008
Last price change
01/12/2023
Co-payment
40%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Janumet Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 50/500 mg56 StkCHF 23.69CHF 41.3001/05/2008B7680584500016
Filmtabl 50/500 mg196 StkCHF 82.94CHF 103.5501/05/2008B7680584500030
Filmtabl 50/850 mg56 StkCHF 23.69CHF 41.3001/05/2008B7680584500054
Filmtabl 50/850 mg196 StkCHF 82.94CHF 103.5501/05/2008B7680584500078
Filmtabl 50/1000 mg56 StkCHF 23.69CHF 41.3001/05/2008B7680584500092
Filmtabl 50/1000 mg196 StkCHF 82.94CHF 103.5501/05/2008B7680584500115

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/12/2020

Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche mit Diät und gesteigerter körperlicher Aktivität und den bisherigen oralen Therapien und/oder Insulin nur ungenügend eingestellt werden können oder diese nicht vertragen.
- Wenn weder mit Metformin noch mit Sitagliptin als Monotherapie eine ausreichende Kontrolle der Glykämie erreicht wird, oder bei Patienten, die bereits eine Kombination von Sitagliptin und Metformin erhalten.
- Als Dreifachkombination in Kombination mit einem Sulfonylharnstoff, wenn durch eine Kombination von zwei der drei folgenden Wirkstoffe keine ausreichende Kontrolle der Glykämie erreicht wird: Metformin, Sitagliptin oder ein Sulfonylharnstoff.
- In Kombination mit Insulin, wenn durch diese Massnahme keine ausreichende Kontrolle der Glykämie erreicht wird.

More preparations in this group

FAQ

Is Janumet covered by Swiss health insurance?

Yes, but only under conditions. Janumet is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Janumet cost in Switzerland?

The public price is the maximum price set by the FOPH and for Janumet ranges from CHF 41.30 to CHF 103.55 per pack. The ex-factory price ranges from CHF 23.69 to CHF 82.94. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com